# Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib

> **NCT01060202** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 60 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** No intervention

## Key facts

- **NCT ID:** NCT01060202
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060202, "Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01060202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*